Beyond Air, Inc. (XAIR)
NCM · Common · CUSIP 08862L202
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for XAIR and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
08862L202 (prev. 08862L103 )
Market Cap
Small Cap
Previous Symbol
AITB (changed 7/15/2019)
Business: Beyond Air, Inc. is a clinical-stage medical device and biopharmaceutical company developing a revolutionary Nitric Oxide "NO" Generator and Delivery System that uses Nitric Oxide generated from ambient air and delivers precise amounts of Nitric Oxide to the lungs for the potential treatment of respiratory and other diseases. The Beyond Air Nitric Oxide Delivery System can generate up to 400 ppm of Nitric Oxide for delivery either continuously or for a fixed amount of time and has the ability to either titrate dose on-demand or maintain a constant dose.
Notes: July 15, 2019 -- Beyond Air, Inc. (NASDAQ: XAIR), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions including serious lung infections and pulmonary hypertension, today announced that it has changed its NASDAQ ticker symbol from AITB to XAIR. The change is effective today, Monday, July 15, 2019.

Company Contact

CEO
Steven Lisi
CFO
Dan Moorhead
Headquarters
900 Stewart Avenue, Suite 301, Garden City, NY 11530
Phone
516-665-8200
Investor Relations
Bob Yedid, LifeSci Advisors, LLC · 646-889-1200 · Bob@LifeSciAdvisors.com
General Email
IR@beyondair.net
Email Form
Contact Form »
SEC EDGAR Filings
View filings »